Parkinson Disease
2,474
411
512
1,225
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
262 trials with published results (11%)
Research Maturity
1225 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.8%
119 terminated out of 2474 trials
91.1%
+4.6% vs benchmark
5%
133 trials in Phase 3/4
21%
262 of 1225 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1225 completed trials
Clinical Trials (2474)
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
Effects of Whole Body Vibration Versus Proprioceptive Neuromuscular Facilitation Pattern With Rhythmic Based Training on Clinical Outcomes in Patients With Parkinson's Disease.
Remote Monitoring in Progressive Supranuclear Palsy (PSP)
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
"Turkish Validity and Reliability of the Heat Sensitivity Scale for Individuals With Parkinson's Disease"
Motor Network Physiology
Study of Transanal Irrigation vs Standard Care for Constipation, Gut Microbiota, and Motor Disorders in Parkinson's Disease
Subthalamic Nucleus (STN)-Targeted Transcranial Temporal Interference Stimulation (TIS) for Parkinson's Disease: Efficacy and Safety From a Single-Center, Prospective, Double-Blind Randomized Controlled Trial
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Clinical and Physiological Studies of Tremor Syndromes
Neuro-immune Interactome in Parkinson's Disease
Deep Brain Stimulation for Patients With Parkinson's Disease.
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases